TrialDiabetes technology & therapeutics2015

Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.

Frances Stringer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.